Chemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathways

Xin-Hua Liao(Fujian Medical University), Kun Ping Lu(Translational Therapeutics (United States))

Scientific Reports

March 6, 2017

10.1038/srep43639

Cited by 53

Related Papers

Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma

|Oncotarget|2017|38

Reciprocal inhibition of PIN1 and APC/CCDH1 controls timely G1/S transition and creates therapeutic vulnerability

|Research Square|2023|3